These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6208030)
1. Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. IV. Interaction of 99mTc-DMS and 99Tc-DMS complexes with blood serum proteins. Vanlić-Razumenic N; Petrovic J; Gorkic D Eur J Nucl Med; 1984; 9(8):370-3. PubMed ID: 6208030 [TBL] [Abstract][Full Text] [Related]
2. Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. II. Subcellular localization of 99Tc-DMS complex in the rat kidney in vivo. Vanlić-Razumenić N; Petrović J Eur J Nucl Med; 1982; 7(7):304-7. PubMed ID: 6288382 [TBL] [Abstract][Full Text] [Related]
3. Preparation of technetium-99-DMS renal complex in solution and its chemical and biological characterization. Vanlić-Razumenić N; Petrović J Int J Appl Radiat Isot; 1982 Apr; 33(4):277-84. PubMed ID: 6282761 [TBL] [Abstract][Full Text] [Related]
4. Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. III. Subcellular distribution and interaction of 99Tc-DMS complex with macromolecules in rat kidney homogenates in vitro. Petrović J; Vanlić-Razumenić N Eur J Nucl Med; 1982; 7(7):308-10. PubMed ID: 6288383 [TBL] [Abstract][Full Text] [Related]
5. Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. I. Subcellular localization of 99mTc-DMS complex in the rat kidney in vivo. Vanlić-Razumenić N; Petrović J Eur J Nucl Med; 1981 Apr; 6(4):169-72. PubMed ID: 6260501 [TBL] [Abstract][Full Text] [Related]
6. Physico-chemical study of the radiopharmaceuticals 99mTc-DMSA, 99mTc-EDTA and 99mTc-DTPA interaction with plasmatic proteins. Garcia Domenech R; Abril Mendez O; Galvez Alvarez J; Farga Marti A Int J Rad Appl Instrum A; 1989; 40(6):536-8. PubMed ID: 2551850 [TBL] [Abstract][Full Text] [Related]
7. The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent. Yokoyama A; Hata N; Horiuchi K; Masuda H; Saji H; Ohta H; Yamamoto K; Endo K; Torizuka K Int J Nucl Med Biol; 1985; 12(4):273-9. PubMed ID: 3002999 [TBL] [Abstract][Full Text] [Related]
8. Comparative chemical, biological and clinical studies of 99mtc-glucoheptonate and 99mtc-dimercaptosuccinate as used in renal scintigraphy. Vanlić-Razumenić N; Malesević M; Stefanović L Nuklearmedizin; 1979 Feb; 18(1):40-5. PubMed ID: 219419 [TBL] [Abstract][Full Text] [Related]
9. Stability of the radiopharmaceutical [99mTc]DMSA: study of the ligand exchange reaction with [99Tc]EDTA. Garcia Muñoz M; Garcia Domenech R; Galvez Alvarez J; Moreno Frigols J Int J Appl Radiat Isot; 1983 Nov; 34(11):1505-8. PubMed ID: 6315599 [TBL] [Abstract][Full Text] [Related]
10. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors. Yee CA; Lee HB; Blaufox MD J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511 [TBL] [Abstract][Full Text] [Related]
11. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake. de Lange MJ; Piers DA; Kosterink JG; van Luijk WH; Meijer S; de Zeeuw D; van der Hem GK J Nucl Med; 1989 Jul; 30(7):1219-23. PubMed ID: 2544699 [TBL] [Abstract][Full Text] [Related]
12. Renal handling of technetium-99m DMSA: further evidence for glomerular filtration and proximal tubular reabsorption. van Luijk WH; Piers DA; Beekhuis H; Meijer S J Nucl Med; 1986 Dec; 27(12):1943. PubMed ID: 3023565 [No Abstract] [Full Text] [Related]
14. Comparative examinations of 99mTc-DMS preparations obtained by labelling dimercaptosuccinate kits with different formulations. I. Comparison of chemical and biological characteristics of Tc P-5 and TCK-12 kits. Vanlić-Razumenić N Nuklearmedizin; 1980 Feb; 19(1):37-40. PubMed ID: 6250133 [TBL] [Abstract][Full Text] [Related]
15. Studies of chemical and biological properties of 99mTc-DMS (dimercaptosuccinic acid)--renal imaging agent. Vanlić-Razumenić NM; Gorkić DA Eur J Nucl Med; 1976 Dec; 1(4):235-42. PubMed ID: 1031368 [TBL] [Abstract][Full Text] [Related]
16. [Fixation of tubules with radioactive technetium dimercaptosuccinate in parenchymal diseases of the kidney]. Rajić M; Bogićević M; Stefanović V Srp Arh Celok Lek; 1993; 121(8-12):113-6. PubMed ID: 7725148 [TBL] [Abstract][Full Text] [Related]
17. [The study on the in-vitro stability of Tc(V)-99m dimercaptosuccinic acid]. Lee BF; Chung KL; Jong SB; Yang CC; Chen CL; Chen YJ; Chen SL; Yu HS; Ting G; Shen LH Kaohsiung J Med Sci; 1996 Sep; 12(9):495-502. PubMed ID: 8819352 [TBL] [Abstract][Full Text] [Related]
18. Comparative examinations of 99mTc-DMS preparations obtained by labelling dimercaptosuccinate kits with different formulations. II. Comparison of chemical and biological characteristics of TcP-5 and MPI kits. Vanlić-Razumenić N Nuklearmedizin; 1981 Feb; 20(1):46-9. PubMed ID: 6264403 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of 99mTc-dimercaptosuccinic acid renal uptake as an index of individual kidney function after acute ureteral obstruction and desobstruction. An experimental study in rats. Schelfhout W; Simons M; Oosterlinck W; De Sy WA Eur Urol; 1983; 9(4):221-6. PubMed ID: 6307703 [TBL] [Abstract][Full Text] [Related]
20. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]